Cargando…
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus
SIMPLE SUMMARY: Immune checkpoint inhibitor-induced insulin-dependent diabetes mellitus (ICI-induced IDDM) is an emerging form of autoimmune diabetes. We describe the characteristics of 34 patients who developed ICI-induced IDDM across five Canadian cancer centres. We observed that presentation with...
Autores principales: | Muniz, Thiago P., Araujo, Daniel V., Savage, Kerry J., Cheng, Tina, Saha, Moumita, Song, Xinni, Gill, Sabrina, Monzon, Jose G., Grenier, Debjani, Genta, Sofia, Allen, Michael J., Arteaga, Diana P., Saibil, Samuel D., Butler, Marcus O., Spreafico, Anna, Hogg, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750429/ https://www.ncbi.nlm.nih.gov/pubmed/35008256 http://dx.doi.org/10.3390/cancers14010089 |
Ejemplares similares
-
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre
por: Koch Hein, Erica C., et al.
Publicado: (2023) -
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
por: Rose, April A N, et al.
Publicado: (2021) -
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events
por: Araujo, Daniel V., et al.
Publicado: (2021) -
Candies
Publicado: (1871) -
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
por: Kelly, Deirdre, et al.
Publicado: (2021)